(CHSRII) UBS(Lux)Fund Solutions – - Ratings and Ratios
Swiss Stocks, Equity Funds, Index Funds
Description: CHSRII UBS(Lux)Fund Solutions –
The UBS(Lux)Fund Solutions – MSCI Switzerland IMI Socially Responsible UCITS ETF(CHF)A-acc is an exchange-traded fund (ETF) that tracks the Morningstar Switzerland TME NR CHF index, providing investors with exposure to Swiss equities that meet certain socially responsible investing (SRI) criteria.
As a Switzerland Equity ETF, it is designed to capture the performance of the Swiss market, with a focus on companies that demonstrate strong environmental, social, and governance (ESG) practices. The funds underlying index is likely composed of a diversified portfolio of large-cap, mid-cap, and potentially small-cap Swiss stocks that meet the SRI criteria.
From a quantitative perspective, key performance indicators (KPIs) such as the funds tracking error, information ratio, and Sharpe ratio would be essential in evaluating its effectiveness in replicating the underlying index and its risk-adjusted returns. Additionally, metrics like the funds dividend yield, price-to-earnings (P/E) ratio, and sector allocation can provide insights into its investment characteristics and potential areas of strength or weakness.
With an AUM of 202.66M CHF, the fund has a moderate size, which may impact its liquidity and trading costs. Further analysis of the funds holdings, sector allocation, and ESG metrics would be necessary to determine its overall investment profile and potential for long-term performance.
Additional Sources for CHSRII ETF
CHSRII ETF Overview
| Market Cap in USD | 255m |
| Category | Switzerland Equity |
| TER | 0.30% |
| IPO / Inception | 2021-02-26 |
CHSRII ETF Ratings
| Growth Rating | 25.2 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | -9.09 |
| Analysts | - |
| Fair Price Momentum | 12.90 CHF |
| Fair Price DCF | - |
CHSRII Dividends
Currently no dividends paidCHSRII Growth Ratios
| Growth Correlation 3m | 35.5% |
| Growth Correlation 12m | 43% |
| Growth Correlation 5y | 45.3% |
| CAGR 5y | 3.50% |
| CAGR/Max DD 5y | 0.13 |
| Sharpe Ratio 12m | 0.66 |
| Alpha | -5.97 |
| Beta | 0.535 |
| Volatility | 12.13% |
| Current Volume | 2.8k |
| Average Volume 20d | 3.6k |
| Stop Loss | 13.8 (-3.2%) |
As of July 16, 2025, the stock is trading at CHF 14.25 with a total of 2,778 shares traded.
Over the past week, the price has changed by +0.69%, over one month by -0.31%, over three months by +7.87% and over the past year by +2.55%.
Neither. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 25.24 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHSRII is around 12.90 CHF . This means that CHSRII is currently overvalued and has a potential downside of -9.47%.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
According to our own proprietary Forecast Model, CHSRII UBS(Lux)Fund Solutions – will be worth about 14.4 in July 2026. The stock is currently trading at 14.25. This means that the stock has a potential upside of +1.12%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.4 | 1.1% |